Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
19.04
-0.92 (-4.61%)
Mar 31, 2025, 9:45 AM EDT - Market open

Company Description

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications.

The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries.

The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations.

It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates.

Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Schrödinger, Inc.
Schrödinger logo
Country United States
Founded 1990
IPO Date Feb 6, 2020
Industry Health Information Services
Sector Healthcare
Employees 891
CEO Ramy Farid

Contact Details

Address:
1540 Broadway, 24th Floor
New York, New York 10036
United States
Phone 212 295 5800
Website schrodinger.com

Stock Details

Ticker Symbol SDGR
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $17.00
CIK Code 0001490978
CUSIP Number 80810D103
ISIN Number US80810D1037
Employer ID 95-4284541
SIC Code 2834

Key Executives

Name Position
Dr. Ramy Farid Ph.D. Chief Executive Officer, President and Director
Dr. Richard A. Friesner Ph.D. Co-Founder, Scientific Advisory Chairman and Director
Dr. Geoffrey Craig Porges MBBS Executive Vice President and Chief Financial Officer
Dr. Robert Lorne Abel Ph.D. Executive Vice President, Chief Scientific Officer of Platform and Head of Modeling Research & Development
Dr. Karen Akinsanya Ph.D. President of Research and Development Therapeutics
Dr. Margaret Han Dugan M.D. Chief Medical Officer
Prof. William Goddard III Co-Founder and Scientific Advisor
Kenneth Patrick Lorton Executive Vice President, Chief Technology Officer and Chief Operating Officer of Software
Shane Brauner Executive Vice President and Chief Information Officer
Jaren Irene Madden Senior Vice President of Investor Relations and Corporate Affairs

Latest SEC Filings

Date Type Title
Mar 10, 2025 8-K Current Report
Mar 6, 2025 144 Filing
Mar 3, 2025 144 Filing
Feb 26, 2025 10-K Annual Report
Feb 26, 2025 8-K Current Report
Feb 18, 2025 144 Filing
Feb 13, 2025 SCHEDULE 13G/A Filing
Feb 11, 2025 144 Filing
Feb 11, 2025 144 Filing
Feb 11, 2025 144 Filing